Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000833299-98-000002
Filing Date
1998-03-31
Accepted
1998-03-31 00:00:00
Documents
15
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 SERAGEN, INC. 10-K 376027
2 CERTIFICATE OF DESIGNATION OF SERIES D PREFERRED STOCK EX-4.9 19858
3 ASSIGNMENT OF SUBLEASE FOR 97 SOUTH STREET EX-10.96 4512
4 ASSIGNMENT OF SUBLEASE FOR 99 SOUTH STREET EX-10.97 4369
5 CONSULTING AGREEMENT WITH DR. JOHN R. MURPHY EX-10.98 1771
6 SUBLEASE AGREEMENT FOR PREMISES AT 97 SOUTH STREET EX-10.99 6710
7 SUBLEASE AGREEMENT FOR PREMISES AT 99 SOUTH STREET EX-10.100 9369
8 WAIVER NO. 5 TO EMPLOYMENT AGREEMENT OF REED PRIOR EX-10.101 1398
9 WAIVER NO. 3 TO EMPLOYMENT AGREEMENT OF ELIZABETH CHEN EX-10.102 1459
10 WAIVER TO EMPLOYMENT AGREEMENT OF JEAN NICHOLS EX-10.103 1366
11 STOCKHOLDERS WAIVER AGREEMENT EX-10.104 4423
12 LIST OF SUBSIDIARIES EX-21 343
13 CONSENT OF ARTHUR ANDERSEN LLP EX-23.1 602
14 CONSENT OF COOPERS & LYBRAND L.L.P. EX-23.2 902
15 ARTICLE 5 FINANCIAL DATE SCHEDULE EX-27 2324
  Complete submission text file 0000833299-98-000002.txt   438523
Mailing Address 97 SOUTH ST HOPKINTON MA 01748
Business Address 97 SOUTH ST HOPKINTON MA 01748 5084352331
SERAGEN INC (Filer) CIK: 0000833299 (see all company filings)

EIN.: 042662345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19855 | Film No.: 98581983
SIC: 2836 Biological Products, (No Diagnostic Substances)